Product Information
FLUOXETINE 20 MG/5 ML SOLUTION is a generic product labeled by PAI Holdings LLC, priced at $0.2142 per ML under NDC 00121072104. Its NADAC has been published 621 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 2002.
Strength
20 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121072104
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076015FDA Approved
1/30/2002
On Market Since
1/30/2002
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has been published 621 times since Nov 28, 2013, and over the history we have for it it has risen 511.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2142 per ML |
|---|---|
| All-time high | $0.5093 (Jul 15, 2020) |
| All-time low | $0.0328 (Jun 18, 2014) |
| 52-week high | $0.2252 |
| 52-week low | $0.2076 |
| Median price | $0.2127 |
| Average price | $0.1972 |
| Largest weekly change | +319.9% (May 29, 2019) |
| Weeks tracked | 621 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.7%
1Y
+3.2%
3Y
-14.8%
5Y
-41.9%
All
+511.6%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FLUOXETINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FLUOXETINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE 20 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE 20 MG/5 ML SOLUTION, manufactured by PAI Holdings LLC, is $0.2142 per ML (NDC 00121072104), effective Apr 29, 2026.
How has the price of FLUOXETINE 20 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has risen 511.6%. It has been tracked across 621 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUOXETINE 20 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for FLUOXETINE 20 MG/5 ML SOLUTION has ranged from a low of $0.0328 (Jun 18, 2014) to a high of $0.5093 (Jul 15, 2020), with a median of $0.2127 per ML.
Are there cheaper alternatives to FLUOXETINE 20 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of FLUOXETINE 20 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOXETINE 20 MG/5 ML SOLUTION?
FLUOXETINE 20 MG/5 ML SOLUTION (NDC 00121072104) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.